BriaCell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.
CEOWilliam V. Williams
CEOWilliam V. Williams
Employees17
Employees17
HeadquartersWest Vancouver, British Columbia
HeadquartersWest Vancouver, British Columbia
Founded2006
Founded2006
Employees17
Employees17
BCTX Key Statistics
Market cap23.57M
Market cap23.57M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume58.83K
Average volume58.83K
High today$12.77
High today$12.77
Low today$11.50
Low today$11.50
Open price$11.62
Open price$11.62
Volume51.14K
Volume51.14K
52 Week high$190.50
52 Week high$190.50
52 Week low$6.00
52 Week low$6.00
Stock Snapshot
As of today, BriaCell Therapeutics(BCTX) shares are valued at $12.77. The company's market cap stands at 23.57M, with a P/E ratio of -0.15.
During the trading session on 2025-12-08, BriaCell Therapeutics(BCTX) shares reached a daily high of $12.77 and a low of $11.50. At a current price of $12.77, the stock is +11.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 51.14K, compared to an average daily volume of 58.83K.
The stock's 52-week range extends from a low of $6.00 to a high of $190.50.
The stock's 52-week range extends from a low of $6.00 to a high of $190.50.
People also own
Based on the portfolios of people who own BCTX. This list is generated using Robinhood data, and it’s not a recommendation.